Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism

Patients infected with the Dengue virus (DENV) often present with a massive generation of DENV-specific antibody-secreting cells (ASCs) in the blood. In some cases, these ASCs represent more than 50% of the circulating B cells, a higher magnitude than those induced by other infections, vaccinations,...

Full description

Bibliographic Details
Main Authors: Vivian Bonezi, Allan H. D. Cataneo, Maryana S. F. Branquinho, Maysa B. B. Silva, Patricia Gonzalez-Dias, Samuel S. Pereira, Luís C. de Souza Ferreira, Helder I. Nakaya, Ana Campa, Pryscilla F. Wowk, Eduardo L. V. Silveira
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.00020/full
id doaj-df61bf3672ec409eb8ab728ef2a32bf5
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Vivian Bonezi
Allan H. D. Cataneo
Maryana S. F. Branquinho
Maysa B. B. Silva
Patricia Gonzalez-Dias
Patricia Gonzalez-Dias
Samuel S. Pereira
Luís C. de Souza Ferreira
Helder I. Nakaya
Helder I. Nakaya
Ana Campa
Pryscilla F. Wowk
Eduardo L. V. Silveira
spellingShingle Vivian Bonezi
Allan H. D. Cataneo
Maryana S. F. Branquinho
Maysa B. B. Silva
Patricia Gonzalez-Dias
Patricia Gonzalez-Dias
Samuel S. Pereira
Luís C. de Souza Ferreira
Helder I. Nakaya
Helder I. Nakaya
Ana Campa
Pryscilla F. Wowk
Eduardo L. V. Silveira
Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism
Frontiers in Immunology
Dengue virus
B cell differentiation
antibody-secreting cells
tryptophan metabolism
flaviviruses
author_facet Vivian Bonezi
Allan H. D. Cataneo
Maryana S. F. Branquinho
Maysa B. B. Silva
Patricia Gonzalez-Dias
Patricia Gonzalez-Dias
Samuel S. Pereira
Luís C. de Souza Ferreira
Helder I. Nakaya
Helder I. Nakaya
Ana Campa
Pryscilla F. Wowk
Eduardo L. V. Silveira
author_sort Vivian Bonezi
title Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism
title_short Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism
title_full Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism
title_fullStr Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism
title_full_unstemmed Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism
title_sort flavivirus-mediating b cell differentiation into antibody-secreting cells in humans is associated with the activation of the tryptophan metabolism
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-02-01
description Patients infected with the Dengue virus (DENV) often present with a massive generation of DENV-specific antibody-secreting cells (ASCs) in the blood. In some cases, these ASCs represent more than 50% of the circulating B cells, a higher magnitude than those induced by other infections, vaccinations, and plasma cell lymphomas. However, it remains unclear how the DENV infection elicits this colossal response. To address this issue, we utilised an in vitro strategy to induce human PBMCs of healthy individuals incubated with DENV particles (DENV4 TVP/360) to differentiate into ASCs. As controls, PBMCs were incubated with a mitogen cocktail or supernatants of uninfected C6/36 cells (mock). The ASC phenotype and function were increasingly detected in the DENV and mitogen-cultured PBMCs as compared to mock-treated cells. In contrast to the in vivo condition, secreted IgG derived from the PBMC-DENV culture was not DENV-specific. Lower ASC numbers were observed when inactivated viral particles or purified B cells were added to the cultures. The physical contact was essential between B cells and the remaining PBMCs for the DENV-mediated ASC response. Considering the evidence for the activation of the tryptophan metabolism detected in the serum of Dengue patients, we assessed its relevance in the DENV-mediated ASC differentiation. For this, tryptophan and its respective metabolites were quantified in the supernatants of cell cultures through mass spectrophotometry. Tryptophan depletion and kynurenine accumulation were found in the supernatants of PBMC-DENV cultures, which presented enhanced detection of indoleamine 2,3-dioxygenase 1 and 2 transcripts as compared to controls. In PBMC-DENV cultures, tryptophan and kynurenine levels strongly correlated to the respective ASC numbers, while the kynurenine levels were directly proportional to the secreted IgG titers. Contrastingly, PBMCs incubated with Zika or attenuated Yellow Fever viruses showed no correlation between their kynurenine concentrations and ASC numbers. Therefore, our data revealed the existence of distinct pathways for the DENV-mediated ASC differentiation and suggest the involvement of the tryptophan metabolism in this cellular process triggered by flavivirus infections.
topic Dengue virus
B cell differentiation
antibody-secreting cells
tryptophan metabolism
flaviviruses
url https://www.frontiersin.org/article/10.3389/fimmu.2020.00020/full
work_keys_str_mv AT vivianbonezi flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT allanhdcataneo flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT maryanasfbranquinho flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT maysabbsilva flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT patriciagonzalezdias flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT patriciagonzalezdias flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT samuelspereira flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT luiscdesouzaferreira flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT helderinakaya flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT helderinakaya flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT anacampa flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT pryscillafwowk flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
AT eduardolvsilveira flavivirusmediatingbcelldifferentiationintoantibodysecretingcellsinhumansisassociatedwiththeactivationofthetryptophanmetabolism
_version_ 1725335071544573952
spelling doaj-df61bf3672ec409eb8ab728ef2a32bf52020-11-25T00:28:39ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-02-011110.3389/fimmu.2020.00020503532Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan MetabolismVivian Bonezi0Allan H. D. Cataneo1Maryana S. F. Branquinho2Maysa B. B. Silva3Patricia Gonzalez-Dias4Patricia Gonzalez-Dias5Samuel S. Pereira6Luís C. de Souza Ferreira7Helder I. Nakaya8Helder I. Nakaya9Ana Campa10Pryscilla F. Wowk11Eduardo L. V. Silveira12Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, BrazilLaboratório de Virologia Molecular, Instituto Carlos Chagas (ICC/Fiocruz Paraná), Curitiba, BrazilDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, BrazilDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, BrazilDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, BrazilScientific Platform Pasteur, University of São Paulo, São Paulo, BrazilDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, BrazilDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, BrazilDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, BrazilScientific Platform Pasteur, University of São Paulo, São Paulo, BrazilDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, BrazilLaboratório de Virologia Molecular, Instituto Carlos Chagas (ICC/Fiocruz Paraná), Curitiba, BrazilDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, BrazilPatients infected with the Dengue virus (DENV) often present with a massive generation of DENV-specific antibody-secreting cells (ASCs) in the blood. In some cases, these ASCs represent more than 50% of the circulating B cells, a higher magnitude than those induced by other infections, vaccinations, and plasma cell lymphomas. However, it remains unclear how the DENV infection elicits this colossal response. To address this issue, we utilised an in vitro strategy to induce human PBMCs of healthy individuals incubated with DENV particles (DENV4 TVP/360) to differentiate into ASCs. As controls, PBMCs were incubated with a mitogen cocktail or supernatants of uninfected C6/36 cells (mock). The ASC phenotype and function were increasingly detected in the DENV and mitogen-cultured PBMCs as compared to mock-treated cells. In contrast to the in vivo condition, secreted IgG derived from the PBMC-DENV culture was not DENV-specific. Lower ASC numbers were observed when inactivated viral particles or purified B cells were added to the cultures. The physical contact was essential between B cells and the remaining PBMCs for the DENV-mediated ASC response. Considering the evidence for the activation of the tryptophan metabolism detected in the serum of Dengue patients, we assessed its relevance in the DENV-mediated ASC differentiation. For this, tryptophan and its respective metabolites were quantified in the supernatants of cell cultures through mass spectrophotometry. Tryptophan depletion and kynurenine accumulation were found in the supernatants of PBMC-DENV cultures, which presented enhanced detection of indoleamine 2,3-dioxygenase 1 and 2 transcripts as compared to controls. In PBMC-DENV cultures, tryptophan and kynurenine levels strongly correlated to the respective ASC numbers, while the kynurenine levels were directly proportional to the secreted IgG titers. Contrastingly, PBMCs incubated with Zika or attenuated Yellow Fever viruses showed no correlation between their kynurenine concentrations and ASC numbers. Therefore, our data revealed the existence of distinct pathways for the DENV-mediated ASC differentiation and suggest the involvement of the tryptophan metabolism in this cellular process triggered by flavivirus infections.https://www.frontiersin.org/article/10.3389/fimmu.2020.00020/fullDengue virusB cell differentiationantibody-secreting cellstryptophan metabolismflaviviruses